Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-002673
Accepted
2025-08-20 00:15:09
Documents
1
Effectiveness Date
2025-08-19

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 620
  Complete submission text file 9999999995-25-002673.txt   1896
Mailing Address 256 E. GRAND AVENUE, SUITE 104 SOUTH SAN FRANCISCO CA 94080
Business Address 256 E. GRAND AVENUE, SUITE 104 SOUTH SAN FRANCISCO CA 94080 857 702 0377
BridgeBio Oncology Therapeutics, Inc. (Filer) CIK: 0001869105 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-288222 | Film No.: 251233714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)